menu
    • menu

    Company profile for Cedars-Sinai

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Cedars-Sinai, our surgeons offer expert care for a wide range of conditions, from routine to complex. We provide safe, effective procedures so you can live the life you deserve. The experienced Cedars-Sinai surgical team helps you through this next bend of your healthcare path. We are with you at every step, from your first appointment through surgery and recovery.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cedars-SinaiUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8700 Beverly Blvd #2900A, Los Angeles, CA 90048
    Telephone
    Telephone
    310-423-3464
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cedars-sinai.org/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Briacell Expands Phase 3 Metastatic Breast Cancer Study Sites
    Briacell Expands Phase 3 Metastatic Breast Cancer Study Sites

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170091/0/en/BriaCell-Adds-Key-Clinical-Sites-in-Phase-3-Metastatic-Breast-Cancer-Study.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Protagonist's Icotrokinra Ph 2b Data to be Presented at UEG Week
    Protagonist's Icotrokinra Ph 2b Data to be Presented at UEG Week

    15 Sep 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/protagonist-announces-icotrokinra-phase-2b-anthem-uc-trial-data-to-be-1073229

    ACCESSWIRE
    15 Sep 2025
    Share Share
    Cedars-Sinai Medical Center Joins Phase I Study of ABVC BioPharma’s Medication
    Cedars-Sinai Medical Center Joins Phase I Study of ABVC BioPharma’s Medication

    02 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/11/02/2546531/0/en/Cedars-Sinai-Medical-Center-Joins-Phase-I-Clinical-Study-of-ABVC-BioPharma-s-Medication-for-Treating-Depression-in-Cancer-Patients.html

    GLOBENEWSWIRE
    02 Nov 2022
    Share Share
    CT scan-reading AI predicts pancreatic cancer early: study
    CT scan-reading AI predicts pancreatic cancer early: study

    02 May 2022

    // Andrea Park FIERCEBIOTECH

    https://www.fiercebiotech.com/medtech/cedars-sinai-ai-analyzes-ct-scans-catch-pancreatic-cancer-years-advance-study

    Andrea Park FIERCEBIOTECH
    02 May 2022
    Share Share
    AIkido, Cedars-Sinai to co-develop novel immuno-oncology cancer treatment
    AIkido, Cedars-Sinai to co-develop novel immuno-oncology cancer treatment

    14 Mar 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=147376&sid=2

    PHARMABIZ
    14 Mar 2022
    Share Share
    Cedars-Sinai and AIkido to Codevelop Novel Immuno-Oncology Cancer Treatment
    Cedars-Sinai and AIkido to Codevelop Novel Immuno-Oncology Cancer Treatment

    11 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cedars-sinai-medical-center-and-aikido-pharma-inc-to-codevelop-novel-immuno-oncology-cancer-treatment-301500752.html

    PRNEWSWIRE
    11 Mar 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search